S
Sverre E. Kjeldsen
Researcher at University of Oslo
Publications - 771
Citations - 95426
Sverre E. Kjeldsen is an academic researcher from University of Oslo. The author has contributed to research in topics: Blood pressure & Left ventricular hypertrophy. The author has an hindex of 94, co-authored 735 publications receiving 89059 citations. Previous affiliations of Sverre E. Kjeldsen include University of Michigan & Cornell University.
Papers
More filters
Journal ArticleDOI
Regression of electrocardiographic left ventricular hypertrophy is associated with less hospitalization for heart failure in hypertensive patients
Peter M. Okin,Richard B. Devereux,Katherine E. Harris,Sverker Jern,Sverre E. Kjeldsen,Stevo Julius,Jonathan M. Edelman,Björn Dahlöf +7 more
TL;DR: It is suggested that reduction of LVH could play an important mechanistic role in decreasing incident heart failure among treated hypertensive patients, independent of the effects of blood pressure, baseline severity of electrocardiographic LVH, and other risk factors for heart failure.
Journal ArticleDOI
Renal sympathetic denervation in patients with treatment-resistant hypertension after witnessed intake of medication before qualifying ambulatory blood pressure.
Fadl Elmula M. Fadl Elmula,Pavel Hoffmann,Eigil Fossum,Magne Brekke,Eyvind Gjønnæss,Ulla Hjørnholm,Vibeke N. Kjær,Morten Rostrup,Sverre E. Kjeldsen,Ingrid Os,Aud-E Stenehjem,Aud Høieggen +11 more
TL;DR: The findings question whether BP falls in response to RDN in patients with true treatment-resistant hypertension, and additional research must aim to verify potential BP lowering effect and identify a priori responders toRDN before this invasive method can routinely be applied to patients with drug- resistant hypertension.
Journal ArticleDOI
Effects of anthocyanins on cardiovascular risk factors and inflammation in pre-hypertensive men: a double-blind randomized placebo-controlled crossover study.
S S Hassellund,Arnljot Flaa,Arnljot Flaa,Sverre E. Kjeldsen,Sverre E. Kjeldsen,Ingebjørg Seljeflot,Ingebjørg Seljeflot,Anette Karlsen,Iris Erlund,Morten Rostrup +9 more
TL;DR: The present study strengthens the evidence that anthocyanins may increase HDL-cholesterol levels, and this is demonstrated for the first time in prehypertensive and non-dyslipidemic men, however, no other beneficial effects in the short term were found on pathophysiological markers of cardiovascular disease.
Journal ArticleDOI
Electrocardiographic Strain Pattern and Prediction of Cardiovascular Morbidity and Mortality in Hypertensive Patients
Peter M. Okin,Richard B. Devereux,Markku S. Nieminen,Sverker Jern,Lasse Oikarinen,Matti Viitasalo,Lauri Toivonen,Sverre E. Kjeldsen,Stevo Julius,Steven M. Snapinn,Björn Dahlöf +10 more
TL;DR: ECG strain is a marker of increased CV risk in hypertensive patients in the setting of aggressive blood pressure lowering, independent of baseline severity of ECG LVH.
Journal ArticleDOI
Stroke is more common than myocardial infarction in hypertension: analysis based on 11 major randomized intervention trials.
TL;DR: Stroke is more common than myocardial infarction in hypertension: analysis based on 11 major randomized intervention trials.